Cargando…
−148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis
Several studies have reported an association between −148 C/T polymorphism of Axis inhibition protein 2 (Axin2) and cancer risk; however, the results are inconsistent. In this study, a meta-analysis was performed to assess the association between −148 C/T polymorphism of Axin2 and susceptibility to...
Autores principales: | Zhong, AnYuan, Pan, Xue, Shi, MinHua, Xu, HuaJun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524579/ https://www.ncbi.nlm.nih.gov/pubmed/26251618 http://dx.doi.org/10.2147/OTT.S86738 |
Ejemplares similares
-
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis
por: Zhong, Anyuan, et al.
Publicado: (2015) -
An Updated Meta-Analysis of the Association between Tumor Necrosis Factor-α -308G/A Polymorphism and Obstructive Sleep Apnea-Hypopnea Syndrome
por: Zhong, Anyuan, et al.
Publicado: (2014) -
Expression of PD-1 by CD4(+)CD25(+)CD127(low) Treg cells in the peripheral blood of lung cancer patients
por: Zhong, AnYuan, et al.
Publicado: (2015) -
The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis
por: Zhong, Anyuan, et al.
Publicado: (2015) -
New insights into the association between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk
por: Xu, Bin, et al.
Publicado: (2019)